Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS
· Delayed Price · Currency is USD
16.74
0.00 (0.00%)
At close: Dec 1, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Medical Pharmaceuticals | 398.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Pharmaceuticals Growth | 26.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| North America | 251.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 58.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 99.84B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -12.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 47.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 15.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Overseas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|